The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Macdonell R.

Bolnitsa Ostin, Geĭdelberg, shtat Viktorija, Avstralija

Stangel M.

Gannoverskaja meditsinskaja shkola, Gannover, Germanija

Mäurer M.

Caritas Krankenhaus Bad Mergentheim, Bad-Mergenthaĭm, Germanija

Thangavelu K.

Genzyme, kompanija Sanofi, Kembridzh, shtat Massachusets, SShA

Truffinet P.

Genzyme, kompanija Sanofi, Shiĭi-Mazaren, Frantsija

Bozzi S.

Sanofi, Shiĭi-Mazaren, Frantsija

Dive-Pouletty C.

Genzyme, kompanija Sanofi, Shiĭi-Mazaren, Frantsija

Freedman M.S.

Prodemonstrirovan ustojchivyj klinicheskij effekt teriflunomida pri ser'eznyh retsidivah v hode 2 ispytanij fazy III u patsientov s retsidivirujuschimi formami rassejannogo skleroza, TEMSO i TOWER

Authors:

Macdonell R., Stangel M., Mäurer M., Thangavelu K., Truffinet P., Bozzi S., Dive-Pouletty C., Freedman M.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(8‑2): 98‑98

Views: 320

Downloaded: 4

Download PDF (RU)
Contact the author
Table of contents

PRODEMONSTRIROVAN USTOJCHIVYJ KLINICHESKIJ EFFEKT TERIFLUNOMIDA PRI SER'EZNYH RETSIDIVAH V HODE 2 ISPYTANIJ FAZY III U PATSIENTOV S RETSIDIVIRUJUSCHIMI FORMAMI RASSEJANNOGO SKLEROZA, TEMSO I TOWER
PRODEMONSTRIROVAN USTOJCHIVYJ KLINICHESKIJ EFFEKT TERIFLUNOMIDA PRI SER'EZNYH RETSIDIVAH V HODE 2 ISPYTANIJ FAZY III U PATSIENTOV S RETSIDIVIRUJUSCHIMI FORMAMI RASSEJANNOGO SKLEROZA, TEMSO I TOWER

To cite this article:

Macdonell R, Stangel M, Mäurer M, et al. . Prodemonstrirovan ustojchivyj klinicheskij effekt teriflunomida pri ser'eznyh retsidivah v hode 2 ispytanij fazy III u patsientov s retsidivirujuschimi formami rassejannogo skleroza, TEMSO i TOWER. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(8‑2):98‑98. (In Russ.)

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Close metadata

Authors:

Macdonell R.

Bolnitsa Ostin, Geĭdelberg, shtat Viktorija, Avstralija

Stangel M.

Gannoverskaja meditsinskaja shkola, Gannover, Germanija

Mäurer M.

Caritas Krankenhaus Bad Mergentheim, Bad-Mergenthaĭm, Germanija

Thangavelu K.

Genzyme, kompanija Sanofi, Kembridzh, shtat Massachusets, SShA

Truffinet P.

Genzyme, kompanija Sanofi, Shiĭi-Mazaren, Frantsija

Bozzi S.

Sanofi, Shiĭi-Mazaren, Frantsija

Dive-Pouletty C.

Genzyme, kompanija Sanofi, Shiĭi-Mazaren, Frantsija

Freedman M.S.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.